When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 15, 2003.

Where is the headquarters located?

The headquarters is located at: Chodkiewicza 73, 85-667 Bydgoszcz.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $2,878,963, representing an increase of 14.4% compared to 2023.

Yes, the company recorded a net profit of $493,522 in 2024, meaning the company increased its profit by 87.0%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,684,279 in 2024, representing 76% of all operating expenses.

Axfarmsp. z o.o.

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2003-07-15

Share capital

100 000,00 PLN

Activity description

Axfarm is a Polish company operating since 2008, specializing in the sale and promotion of OTC products, dietary supplements, and medical devices supporting ear, nose, and throat health. Its portfolio includes sprays and the Otovent pressure therapy kit. The company promotes products in pharmacies, runs educational campaigns for pharmacists and doctors, and serves B2B and e-commerce sales channels.

Registered address

Chodkiewicza 73/26, 85-667 Bydgoszcz, Poland

Website

axfarm.com.pl

Electronic delivery address

AE:PL-29961-29761-IICEA-29

Financials

Revenue history (in k)

Financial insight

companies.financials.estonianCitCertain

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 2.87mMedianUSD 874.80kAverageUSD 20.30m

Net profit

This companyUSD 495.82kMedianUSD 28.22kAverageUSD 816.54k

Operating costs

This companyUSD 2.33mMedianUSD 805.63kAverageUSD 19.09m

Assets

This companyUSD 2.83mMedianUSD 541.73kAverageUSD 10.95m

Industry

Bank accounts

Registered as a VAT taxpayer on 1999-10-29. Active

Bank Pekao SA
75 1240 1183 1111 0011 0309 1159
Bank Pekao SA
89 1240 1183 1111 0011 0310 9434

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Sep 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,396$1,396	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,680$1,680	Prezes Zakładu Ubezpieczeń Społecznych
May 22, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$135.9K$135,870	Polski Fundusz Rozwoju S.A.

Tenders

No recorded participation in tenders.

Trademarks

Axfarm holds 1 active trademark registered with the Polish Patent Office. 3 marks have expired or were not registered. The first mark was filed in 2003.

Mark	Number	Classes	Status	Protected until
AXFARM(word)	Z.469161	3, 5, 35	Protected	Mar 21, 2027
cerumex	Z.280884	3	Expired	–
axfarm	Z.263417	3, 5, 35	Expired	–
ringosol	Z.261629	3, 5	Expired	–

Mark	Protected until
AXFARM(word)	Mar 21, 2027
cerumex	–
axfarm	–
ringosol	–

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Michał Andrzej Ławicki – President of the Management Board

Manner of representation

If a multi-member management board is appointed, each member of the management board individually is authorized to conduct the affairs of the company (independent representation).

Ownership

Owner	Shares	Share value	Stake
Jerzy Wojciech Bruś (58)	34	$4,592.11	17%
Michał Andrzej Ławicki (58)	166	$22,420.31	83%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Pharm Supplysp. z o.o.	$6,901,751.00	pharmsupply.com.pl
OSSsp. z o.o.	$4,040,410.34	oss.com.pl
Orfamaksp. z o.o. + limited partnership	$3,990,765.46	orfamak.eu
Synergy Tradingsp. z o.o.	$3,055,373.51	synergytrading.com.pl
Farmbudsp. z o.o.	$2,476,637.88	farmbud.eu
Tuttomed Farmacjasp. z o.o.	$2,145,336.42	tuttomed.pl
Eumedsp. z o.o.	$2,086,044.24	eumed.pl
Mercantsp. z o.o.	$1,876,335.96	mercant.pl
AVEC Pharmasp. z o.o.	$1,786,681.69	avecpharma.com
Equadentsp. z o.o.	$1,636,062.40	equadent.pl

Change history

Date	Event
2011-05-30	PKD change (Removed: 22, 24.42.Z, 24.52.Z, 51.46.Z, 51.70.A, 52.32.Z, 73.10.F, 73.20.E, 74.13.Z, 74.14.A, 74.30.Z, 74.40.Z, 74.84.B, 80.42.Z, 85.12.Z, 85.14.A; Added: 10.86.Z, 10.89.Z, 20.42.Z, 21.10.Z, 21.20.Z, 32.50.Z, 46.38.Z, 46.45.Z, 46.46.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 62.01.Z, 63.11.Z, 63.99.Z, 69.20.Z, 70.21.Z, 70.22.Z, 71.20.A, 73.11.Z, 73.20.Z, 77.11.Z, 77.40.Z, 78.20.Z, 78.30.Z, 82.19.Z, 82.20.Z, 82.30.Z)
2009-10-07	Address change (Chodkiewicza 61, 85-667, Bydgoszcz → Chodkiewicza 73/26, 85-667, Bydgoszcz)
2006-08-09	Address change (Kozietulskiego 36/1, 85-657, Bydgoszcz → Chodkiewicza 61, 85-667, Bydgoszcz)
2006-08-09	Share capital change (25,000.00 PLN → 100,000.00 PLN)
2003-07-15	Entered in the register

FAQ

Last updated: 2026-07-04